Edition:
United Kingdom

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

7.47USD
14 Dec 2018
Change (% chg)

$-0.04 (-0.53%)
Prev Close
$7.51
Open
$7.51
Day's High
$7.57
Day's Low
$7.45
Volume
240,124
Avg. Vol
591,063
52-wk High
$7.84
52-wk Low
$2.03

Latest Key Developments (Source: Significant Developments)

Pacific Biosciences Of California Q2 Loss Per Share $0.17
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 REVENUE $21.6 MILLION VERSUS I/B/E/S VIEW $23.8 MILLION.QTRLY LOSS PER SHARE $0.17.PACIFIC BIOSCIENCES OF CALIFORNIA - CASH, CASH EQUIVALENTS AND INVESTMENTS, AT JUNE 30, 2018 TOTALED $63.5 MILLION, VERSUS $62.9 MILLION AT DECEMBER 31, 2017.  Full Article

Pacific Biosciences Of California reports Q3 revenue $23.5 mln
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Pacific Biosciences Of California Inc :Pacific Biosciences Of California Inc announces third quarter 2017 financial results.Q3 revenue $23.5 million versus I/B/E/S view $28.5 million.Pacific Biosciences Of California Inc - ‍net loss for q3 of 2017 was $22.0 million, compared to $17.5 million for q3 of 2016​.Pacific Biosciences Of California Inc qtrly loss per share $‍0.19​.  Full Article

Deals of the day-Mergers and acquisitions

Nov 2 The following bids, mergers, acquisitions and disposals were reported by 1300 GMT on Friday: ** Gene sequencing company Illumina Inc said on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows. ** Australia's MYOB Group said it will grant due diligence to KKR & Co after the U.S. buyout giant sweetened its offer to take full control of the accounting software provi